Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ryan Cullen
Institution:
Medical Research Institute of New Zealand
Observed institution:
Medical Research Institute of New Zealand
ORCID:
0009-0003-5864-7915
Observed ORCID:
0009-0003-5864-7915
OpenAlex ID:
A5122393770
Budesonide–formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): an open-label, parallel-group, randomised, controlled, phase 4 trial
2026
·
Jonathan H Noble
, Orlagh Bean
, et al.
·
The Lancet Respiratory Medicine
·
3
External Validation of the Minimal Clinically Important Difference of FeNO Using the Asthma Control Questionnaire
2025
·
Jonathan Noble
, Orlagh Bean
, et al.
·
Clinical & Experimental Allergy
·
3
PDF
Medium-Dose Compared With High-Dose Inhaled Corticosteroids in Combination Triple Inhaler Therapy for Asthma
2026
·
Samantha Warhurst
, Ryan Cullen
, et al.
·
CHEST Pulmonary
·
2
PDF
Protocol for the INFORM ASTHMA Trial: budesonide–formoterol reliever in adults with asthma on maintenance inhaled corticosteroid
2025
·
Jonathan Noble
, Orlagh Bean
, et al.
·
ERJ Open Research
·
1
A Single-Arm Study of Patient Satisfaction and Clinical Outcomes with an Anti-Inflammatory Reliever Algorithm in relation to Baseline GINA Step
2026
·
Ross Sayers
, Pepa Bruce
, et al.
·
Journal of Allergy and Clinical Immunology Global
PDF
A study protocol for a randomised controlled trial of two stepwise pharmacological treatment approaches to adult asthma: inhaled corticosteroid/formoterol reliever- versus short-acting β 2 -agonist reliever-based therapy – Asthma on TRACK
2026
·
Ross Sayers
, Ryan Cullen
, et al.
·
ERJ Open Research
A framework to define an occasion of asthma reliever inhaler use
2025
·
Jonathan Noble
, Orlagh Bean
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
Show more works
View as search
Works count:
7
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type